跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Recombinant human interferon beta-1b for injection
Approved
生物制品
Recombinant human interferon beta-1b for injection
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
Aug 24, 2023
Approval ID
8TEL8C6OaET
Company
BAYER AG
Type
生物制品
Approval Details
Approval Id
8TEL8C6OaET
Approval Number
国药准字SJ20130094
Generic Name
注射用重组人干扰素β-1b
Generic Name En
Recombinant human interferon beta-1b for injection
Trade Name
倍泰龙
Drug Type
生物制品
Dosage Form
注射剂
Strength
0.3mg/支
Reg Date
2023-08-24
Expired Date
2028-08-23
Company Name
BAYER AG
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 24, 2023
Approval ID
8TEL8C6OaET
Type
生物制品
Back to NMPA Approvals
倍泰龙 - NMPA Drug Approval Details